These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Clinically relevant drug interactions with new generation antidepressants and antipsychotics]. Eckert A Ther Umsch; 2009 Jun; 66(6):485-92. PubMed ID: 19496045 [TBL] [Abstract][Full Text] [Related]
7. Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies. Mika J; Zychowska M; Makuch W; Rojewska E; Przewlocka B Pharmacol Rep; 2013; 65(6):1611-21. PubMed ID: 24553009 [TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy considerations in patients with HIV and psychiatric disorders: focus on antidepressants and antipsychotics. Hill L; Lee KC Ann Pharmacother; 2013 Jan; 47(1):75-89. PubMed ID: 23341158 [TBL] [Abstract][Full Text] [Related]
9. Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders. Baldwin DS Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():12-5. PubMed ID: 24921677 [TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review. Thaler KJ; Morgan LC; Van Noord M; Gaynes BN; Hansen RA; Lux LJ; Krebs EE; Lohr KN; Gartlehner G Depress Anxiety; 2012 Jun; 29(6):495-505. PubMed ID: 22553134 [TBL] [Abstract][Full Text] [Related]
11. Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea. DeVane CL J Clin Psychiatry; 2003; 64 Suppl 18():14-9. PubMed ID: 14700450 [TBL] [Abstract][Full Text] [Related]
13. Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease. Lauterbach EC Am J Neurodegener Dis; 2016; 5(1):29-51. PubMed ID: 27073741 [TBL] [Abstract][Full Text] [Related]
14. Antidepressants in Parkinson's disease. Recommendations by the movement disorder study group of the Neurological Association of Madrid. Peña E; Mata M; López-Manzanares L; Kurtis M; Eimil M; Martínez-Castrillo JC; Navas I; Posada IJ; Prieto C; Ruíz-Huete C; Vela L; Venegas B; Neurologia (Engl Ed); 2016 Mar; ():. PubMed ID: 27004670 [TBL] [Abstract][Full Text] [Related]
15. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders. Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035 [TBL] [Abstract][Full Text] [Related]